Published in Retina on July 01, 2015
Retinal vein occlusion and the use of a dexamethasone intravitreal implant (Ozurdex®) in its treatment. Graefes Arch Clin Exp Ophthalmol (2016) 0.88
Retrospective, controlled observational case study of patients with central retinal vein occlusion and initially low visual acuity treated with an intravitreal dexamethasone implant. BMC Ophthalmol (2016) 0.75
Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. Ophthalmology (2010) 7.30
The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema. Ophthalmology (2011) 6.33
Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study results. Ophthalmology (2011) 4.61
Safety and efficacy of ranibizumab in diabetic macular edema (RESOLVE Study): a 12-month, randomized, controlled, double-masked, multicenter phase II study. Diabetes Care (2010) 3.29
Retreatment with Ozurdex for macular edema secondary to retinal vein occlusion. Eur J Ophthalmol (2013) 2.44
Repeatability and reproducibility of fast macular thickness mapping with stratus optical coherence tomography. Arch Ophthalmol (2005) 2.12
Impact of intravitreal dexamethasone implant (Ozurdex) on macular morphology and function. Retina (2014) 2.11
Intravitreal ranibizumab for naive extrafoveal choroidal neovascularization secondary to age-related macular degeneration. Retina (2014) 2.04
Changes in macular function after ozurdex for retinal vein occlusion. Optom Vis Sci (2014) 2.02
INTRAOCULAR PRESSURE IN PATIENTS WITH DIABETIC MACULAR EDEMA TREATED WITH DEXAMETHASONE INTRAVITREAL IMPLANT IN THE 3-YEAR MEAD STUDY. Retina (2016) 1.92
Anti-vascular endothelial growth factor for diabetic macular oedema. Cochrane Database Syst Rev (2014) 1.86
Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for diabetic macular oedema. Cochrane Database Syst Rev (2012) 1.52
Use of capsular tension ring in phacoemulsification. Indications and technique. Indian J Ophthalmol (2002) 1.50
Retinal functional changes measured by microperimetry in neovascular age-related macular degeneration patients treated with ranibizumab. Retina (2009) 1.47
The effect of ageing on retinal nerve fibre layer thickness: an evaluation by scanning laser polarimetry with variable corneal compensation. Acta Ophthalmol Scand (2006) 1.42
Idiopathic macular hole surgery with low-concentration infracyanine green-assisted peeling of the internal limiting membrane. Am J Ophthalmol (2006) 1.41
Correspondence. Retina (2017) 1.40
Tear osmolarity in ocular graft-versus-host disease. Cornea (2014) 1.40
Choroidal thickness changes with photodynamic therapy for a diffuse choroidal hemangioma in Sturge–Weber syndrome. Int Ophthalmol (2014) 1.39
SD OCT features of dry arcuate longstanding retinal folds. Eur J Ophthalmol (2011) 1.38
Adaptive optics technology for high-resolution retinal imaging. Sensors (Basel) (2012) 1.30
Fixation pattern and macular sensitivity in eyes with subfoveal choroidal neovascularization secondary to age-related macular degeneration. A microperimetry study. Semin Ophthalmol (2004) 1.28
Anxiety and depression prevalence rates in age-related macular degeneration. Invest Ophthalmol Vis Sci (2007) 1.25
Repeated intravitreal dexamethasone implant (Ozurdex®) for retinal vein occlusion. Ophthalmologica (2012) 1.23
Retinal nerve fiber layer thickness reproducibility using seven different OCT instruments. Invest Ophthalmol Vis Sci (2012) 1.23
Guidance for the treatment of neovascular age-related macular degeneration. Acta Ophthalmol Scand (2007) 1.17
Safety of ranibizumab in routine clinical practice: 1-year retrospective pooled analysis of four European neovascular AMD registries within the LUMINOUS programme. Br J Ophthalmol (2013) 1.16
Management of retinal vein occlusion--consensus document. Ophthalmologica (2011) 1.14
Vascularized retinal pigment epithelial detachment in age-related macular degeneration: treatment and RPE tear incidence. Graefes Arch Clin Exp Ophthalmol (2012) 1.14
Intravitreal dexamethasone implant in patients with persistent diabetic macular edema. Ophthalmologica (2012) 1.13
Prevalence of asymptomatic macular holes in highly myopic eyes. Ophthalmology (2005) 1.12
Screening for diabetic retinopathy: 1 and 3 nonmydriatic 45-degree digital fundus photographs vs 7 standard early treatment diabetic retinopathy study fields. Am J Ophthalmol (2009) 1.11
Spontaneous resolution of a shallow detachment of the macula in a highly myopic eye. Am J Ophthalmol (2003) 1.11
Carotenoids and antioxidants in age-related maculopathy italian study: multifocal electroretinogram modifications after 1 year. Ophthalmology (2007) 1.10
Outcome of choroidal neovascularization in angioid streaks after photodynamic therapy. Retina (2004) 1.10
Enhanced depth imaging optical coherence tomography in type 2 diabetes. Invest Ophthalmol Vis Sci (2012) 1.10
Reproducibility of macular thickness measurements using Cirrus SD-OCT in neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci (2010) 1.10
Optical coherence tomography versus stereoscopic fundus photography or biomicroscopy for diagnosing diabetic macular edema: a systematic review. Invest Ophthalmol Vis Sci (2007) 1.09
Correspondence. Retina (2013) 1.08
Bietti crystalline dystrophy: a morpho-functional evaluation. Doc Ophthalmol (2011) 1.06
Correspondence. Retina (2015) 1.05
Optic nerve head and fibre layer imaging for diagnosing glaucoma. Cochrane Database Syst Rev (2015) 1.05
Analysis of progression of reticular pseudodrusen by spectral domain-optical coherence tomography. Invest Ophthalmol Vis Sci (2012) 1.05
Branch retinal vein occlusion: classification and treatment. Ophthalmologica (2009) 1.04
Onset and duration of visual acuity improvement after dexamethasone intravitreal implant in eyes with macular edema due to retinal vein occlusion. Retina (2014) 1.04
Diabetic macular edema: fundus autofluorescence and functional correlations. Invest Ophthalmol Vis Sci (2011) 1.03
Hyperreflective dots: a new spectral-domain optical coherence tomography entity for follow-up and prognosis in exudative age-related macular degeneration. Ophthalmologica (2012) 1.03
Analysis of retinal capillaries in patients with type 1 diabetes and nonproliferative diabetic retinopathy using adaptive optics imaging. Retina (2013) 1.00
Diurnal variation in clinically significant diabetic macular edema measured by the Stratus OCT. Retina (2006) 0.99
Juxtafoveal choroidal neovascularization associated with retinitis pigmentosa treated with intravitreal bevacizumab. J Ocul Pharmacol Ther (2011) 0.99
Photodynamic therapy for juxtafoveal choroidal neovascularization associated with multifocal choroiditis. Am J Ophthalmol (2006) 0.98
Intravitreal ranibizumab versus bevacizumab for treatment of myopic choroidal neovascularization. Retina (2012) 0.98
Macular function in eyes with early age-related macular degeneration with or without contralateral late age-related macular degeneration. Retina (2007) 0.97
Repeated intravitreal dexamethasone implant (Ozurdex) for diabetic macular edema. Retina (2015) 0.95
Intravitreal bevacizumab versus ranibizumab for the treatment of retinal angiomatous proliferation. Acta Ophthalmol (2011) 0.95
Laser photocoagulation, photodynamic therapy, and intravitreal bevacizumab for the treatment of juxtafoveal choroidal neovascularization secondary to pathologic myopia. Arch Ophthalmol (2010) 0.95
Bevacizumab vs photodynamic therapy for choroidal neovascularization in multifocal choroiditis. Arch Ophthalmol (2010) 0.94
Interleukin-1beta tear concentration in glaucomatous and ocular hypertensive patients treated with preservative-free nonselective beta-blockers. Am J Ophthalmol (2005) 0.94
Experience with the Pascal® photocoagulator: an analysis of over 1,200 laser procedures with regard to parameter refinement. Indian J Ophthalmol (2011) 0.93
Adaptive optics imaging of parafoveal cones in type 1 diabetes. Retina (2014) 0.93
Hyperhomocysteinemia and the methylenetetrahydrofolate reductase 677C-T mutation in patients under 50 years of age affected by central retinal vein occlusion. Ophthalmology (2004) 0.93
Patient-reported visual function outcomes improve after ranibizumab treatment in patients with vision impairment due to diabetic macular edema: randomized clinical trial. JAMA Ophthalmol (2013) 0.93
The role of angiogenesis in the development of proliferative diabetic retinopathy: impact of intravitreal anti-VEGF treatment. Exp Diabetes Res (2012) 0.91
Quality of life in patients with uveitis on chronic systemic immunosuppressive treatment. Ocul Immunol Inflamm (2010) 0.91
A 6-month randomized clinical trial of bimatoprost 0.03% versus the association of timolol 0.5% and latanoprost 0.005% in glaucomatous patients. Graefes Arch Clin Exp Ophthalmol (2004) 0.91
Leukaemic infiltration of the retina at onset of Philadelphia-positive acute lymphoblastic leukaemia revealed by stratus optical coherence tomography. Br J Haematol (2006) 0.91
Accidental injection of dexamethasone intravitreal implant in the crystalline lens. Acta Ophthalmol (2013) 0.91
Preferential hyperacuity perimeter as a functional tool for monitoring exudative age-related macular degeneration in patients treated by intravitreal ranibizumab. Invest Ophthalmol Vis Sci (2011) 0.91
Stereotactic radiotherapy for neovascular age-related macular degeneration: 52-week safety and efficacy results of the INTREPID study. Ophthalmology (2013) 0.91
Review on the worldwide epidemiology of uveitis. Eur J Ophthalmol (2013) 0.90
Influence of disc size on optic nerve head versus retinal nerve fiber layer assessment for diagnosing glaucoma. Ophthalmology (2011) 0.90
Sequential anterior ischemic optic neuropathy and central retinal artery and vein occlusion after ranibizumab for diabetic macular edema. Eur J Ophthalmol (2010) 0.90
Retinal venous occlusions: diagnosis and choice of treatments. Ophthalmic Res (2013) 0.90
Intravitreal Ranibizumab for myopic choroidal neovascularization after pars plana vitrectomy and silicone oil tamponade. Eur J Ophthalmol (2013) 0.90
Intravitreal ranibizumab for choroidal neovascularization with large submacular hemorrhage in age-related macular degeneration. Retina (2014) 0.89
Curcumin protects against NMDA-induced toxicity: a possible role for NR2A subunit. Invest Ophthalmol Vis Sci (2011) 0.89
Retinal vein occlusion: current treatment. Ophthalmologica (2010) 0.88
Outcome of 110 basal cell carcinomas of the eyelid treated with frozen section-controlled excision: mean follow-up over 5 years. Eur J Ophthalmol (2013) 0.88
Subthreshold grid laser treatment of macular edema secondary to branch retinal vein occlusion with micropulse infrared (810 nanometer) diode laser. Ophthalmology (2006) 0.88
Intravitreal bevacizumab for extrafoveal choroidal neovascularization after ocular trauma. J Ocul Pharmacol Ther (2012) 0.88
Ranibizumab in the treatment of patients with visual impairment due to diabetic macular edema. Clin Ophthalmol (2011) 0.88
Intravitreal bevacizumab for a subfoveal myopic choroidal neovascularization in the first trimester of pregnancy. J Ocul Pharmacol Ther (2012) 0.87
Angiographic evidence of retinal artery transient occlusion in paracentral acute middle maculopathy. Retina (2014) 0.87
En face enhanced depth imaging optical coherence tomography of fibrovascular pigment epithelium detachment. Invest Ophthalmol Vis Sci (2012) 0.87
Foveal microstructure and functional parameters in lamellar macular hole. Am J Ophthalmol (2012) 0.86
Antivascular endothelial growth factors for inflammatory chorioretinal disorders. Dev Ophthalmol (2010) 0.86
Near-infrared fundus autofluorescence in multiple evanescent white-dot syndrome. Eur J Ophthalmol (2014) 0.86